98 related articles for article (PubMed ID: 25579512)
21. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
[TBL] [Abstract][Full Text] [Related]
22. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
23. MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.
Lu YF; Zhang L; Waye MM; Fu WM; Zhang JF
Exp Cell Res; 2015 May; 334(1):173-82. PubMed ID: 25857406
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
[TBL] [Abstract][Full Text] [Related]
25. miRNA-15a/16: as tumor suppressors and more.
Huang E; Liu R; Chu Y
Future Oncol; 2015; 11(16):2351-63. PubMed ID: 26260813
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
27. miR-21 as a key regulator of oncogenic processes.
Selcuklu SD; Donoghue MT; Spillane C
Biochem Soc Trans; 2009 Aug; 37(Pt 4):918-25. PubMed ID: 19614619
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
[TBL] [Abstract][Full Text] [Related]
29. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
Zhu YK; Cheng N; Hu Y; Cen YZ
Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
[TBL] [Abstract][Full Text] [Related]
30. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
Chen F; Hu SJ
J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
[TBL] [Abstract][Full Text] [Related]
31. miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44.
Zhao H; Ma B; Wang Y; Han T; Zheng L; Sun C; Liu T; Zhang Y; Qiu X; Fan Q
Oncol Rep; 2013 Mar; 29(3):1027-36. PubMed ID: 23314380
[TBL] [Abstract][Full Text] [Related]
32. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS
Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752
[TBL] [Abstract][Full Text] [Related]
33. Up-Regulation of miR-34a Expression in Response to the Luteolin-Induced Neurite Outgrowth of PC12 Cells.
Chen PY; Wu MJ; Chang HY; Tai MH; Ho CT; Yen JH
J Agric Food Chem; 2015 Apr; 63(16):4148-59. PubMed ID: 25865700
[TBL] [Abstract][Full Text] [Related]
34. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
35. The role of miRNAs in cancer: from pathogenesis to therapeutic implications.
Seven M; Karatas OF; Duz MB; Ozen M
Future Oncol; 2014 May; 10(6):1027-48. PubMed ID: 24941988
[TBL] [Abstract][Full Text] [Related]
36. Regulatory and immunomodulatory role of miR-34a in T cell immunity.
Taheri F; Ebrahimi SO; Shareef S; Reiisi S
Life Sci; 2020 Dec; 262():118209. PubMed ID: 32763292
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-124: An emerging therapeutic target in cancer.
Jia X; Wang X; Guo X; Ji J; Lou G; Zhao J; Zhou W; Guo M; Zhang M; Li C; Tai S; Yu S
Cancer Med; 2019 Sep; 8(12):5638-5650. PubMed ID: 31389160
[TBL] [Abstract][Full Text] [Related]
38. microRNAs as cancer therapeutics: A step closer to clinical application.
Catela Ivkovic T; Voss G; Cornella H; Ceder Y
Cancer Lett; 2017 Oct; 407():113-122. PubMed ID: 28412239
[TBL] [Abstract][Full Text] [Related]
39. Emergence of miR-34a in radiation therapy.
Lacombe J; Zenhausern F
Crit Rev Oncol Hematol; 2017 Jan; 109():69-78. PubMed ID: 28010900
[TBL] [Abstract][Full Text] [Related]
40. MiR-34a and endothelial biology.
Li Q; Zhang Q
Life Sci; 2023 Oct; 330():121976. PubMed ID: 37495076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
